Quick exercise before cancer treatment shows promise in early trial

NCT ID NCT07564570

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a short bout of cycling exercise right before immunotherapy (nivolumab and ipilimumab) can boost the immune system and improve treatment outcomes in people with advanced melanoma. Researchers want to see if this approach is practical and safe for patients, many of whom have side effects from their disease or treatment. The goal is to increase cancer-fighting immune cells and potentially improve survival and quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Medical Center Hamburg-Eppendorf

    RECRUITING

    Hamburg, Free and Hanseatic City of Hamburg, 20251, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.